Artificial intelligence to find causes of angina with no blocked arteries (ANOCA)
Official title: Artificial Intelligence-assisted Diagnostics In Angina With No Obstructive Coronary Artery Disease
Run by UMC Utrecht · NCT06387693 · Data updated 2026-11-12
This project will test whether AI analysis of intracoronary ECG and Holter monitoring can help identify vasospasm or microvascular problems in people with ongoing angina but no obstructed coronary arteries.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | UMC Utrecht Academic / other |
| Locations | 1 site (Utrecht) |
| Status | Recruiting |
| Started | December 3, 2024 |
| Main results expected | August 2028 |
| Study ends | December 2028 |
| Registry record updated | January 12, 2026 |
| Trial ID | NCT06387693 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People who have persistent chest discomfort at least twice per week despite medical therapy, no obstructive coronary artery disease on recent CCTA or invasive angiography, and who can give informed consent (and understand Dutch) are ideal candidates.
✕Probably not a fit
Patients with obstructive coronary disease that requires revascularization, those whose chest pain has resolved after therapy, or those unable to communicate in Dutch are unlikely to benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Many patients with angina have no obstructive coronary stenosis, a condition called ANOCA that is linked to poor quality of life and adverse events. During invasive coronary angiography, coronary function testing (CFT) including intracoronary ECG is used to diagnose vasomotor disorders, but the ECG signs can be subtle and hard to interpret. This project combines intracoronary ECG recordings with ambulatory Holter monitoring and applies artificial intelligence to detect the electrocardiographic signs of ischemia that support a diagnosis of vasospasm or microvascular dysfunction. Participants are patients at UMC Utrecht with frequent chest discomfort despite therapy and no obstructive coronary disease on recent imaging or angiography who can provide informed consent.
Why it matters
Potential benefit: If successful, this approach could improve detection of vasospasm and microvascular causes of angina, leading to more targeted treatment and better symptom control.
How similar studies have gone: Coronary function testing and intracoronary ECG are established methods for diagnosing vasomotor disorders, but applying AI to intracoronary ECG and Holter data for ANOCA is a novel approach that has not yet been proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Clinical indication for comprehensive coronary function testing because of persisting chest discomfort at least 2 times per week despite current medical therapy. 2. Absence of obstructive coronary artery disease with an indication for revascularization, documented by means of recent coronary computed tomography angiography (CCTA) or invasive coronary angiography (with invasive coronary pressure measurements if clinically indicated). 3. Patient is willing and able to provide written informed consent. Exclusion Criteria: 1. Absence of chest discomfort after initiation of medical therapy. 2. Language barrier preventing sufficient understanding and communication in Dutch.
Where it's running
-
UMC Utrecht
Utrecht, Netherlands Recruiting
Study contacts
- Study coordinator: Tim P van de Hoef, MD, PhD
- Email: t.p.vandehoef@umcutrecht.nl
- Phone: +3188755555
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Advanced invasive diagnosis for post-PCI angina in patients referred for coronary angiography
This study tests a specialized invasive approach to find the cause of angina in people who previously had PCI and are now referred for coronary angiography.
-
Lesion-specific angina thresholds measured during invasive coronary testing
This project tests whether different coronary narrowings cause angina at different levels of blood-flow reduction in people with stable angina who have two blockages suitable for PCI.
-
SirPlux Duo dual-API drug-coated balloon to treat new and in‑stent coronary blockages
This study tests the SirPlux Duo drug‑coated balloon in adults with symptomatic coronary artery disease who have either new (de novo) small vessel blockages or in‑stent restenosis to see if it is safe and works well.
-
Beta-blockers to improve coronary blood flow and resistance in people with angina and no blocked coronary arteries
This trial will see if a beta-blocker (metoprolol) helps people with angina but no obstructive coronary arteries by improving coronary blood flow and lowering small-vessel resistance compared with a placebo.
-
Effects of aerobic exercise on heart function in patients with heart disease
This study tests whether different types of aerobic exercise can improve heart function in patients with heart disease who have recently had treatment.
-
Acupuncture for reducing pain in stable angina
This study is testing if a specific acupuncture treatment can help people with stable angina feel less pain compared to those who just watch talks for five weeks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.